Puma Biotechnology, Inc.
Clinical trials sponsored by Puma Biotechnology, Inc., explained in plain language.
-
New drug trial offers hope for Tough-to-Treat lung cancer
Disease control Recruiting nowThis study is testing an oral drug called alisertib for people with advanced small cell lung cancer that has worsened after standard chemotherapy and immunotherapy. The main goal is to see if the drug can shrink tumors and control the cancer's growth, and to identify which patien…
Phase: PHASE2 • Sponsor: Puma Biotechnology, Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
New drug combo tested to control Tough-to-Treat breast cancer
Disease control Recruiting nowThis study is testing whether adding an experimental drug called alisertib to standard hormone therapy can better control advanced breast cancer that has stopped responding to previous hormone treatments. It will enroll about 150 adults whose cancer has returned or spread and aim…
Phase: PHASE2 • Sponsor: Puma Biotechnology, Inc. • Aim: Disease control
Last updated Mar 09, 2026 14:24 UTC